Federal Circuit Affirms Claim Construction and How It Applies, PTAB Litigation Blog
Visit the PTAB Litigation Blog
In Pacific Biosciences of California, Inc. v. Personal Genomics Taiwan, Inc., the Federal Circuit recently affirmed two PTAB decisions in IPRs filed by Pacific Biosciences of California, Inc. (PacBio) that challenged a Personal Genomics Taiwan (PGT) patent, U.S. Patent No. 7,767,441, directed to a device for determining the identity of biomolecules. The court agreed both with the PTAB’s claim construction and its application of that construction to the prior art raised in the IPRs.
Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
